Your browser doesn't support javascript.
loading
Study of epirubicin sustained-release chemoablation in tumor suppression and tumor microenvironment remodeling.
Meng, Liangliang; Wang, Zhenjun; Hou, Zhonghui; Wang, Hufei; Zhang, Xiao; Zhang, Xiaobo; He, Xiaofeng; Zhang, Xin; Qin, Boyu; Li, Jing; Zhang, Zhongliang; Xue, Xiaodong; Wei, Yingtian.
Afiliação
  • Meng L; Department of Radiology, Chinese People's Armed Police (PAP) Hospital of Beijing, Beijing, China.
  • Wang Z; Department of Radiology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
  • Hou Z; Department of Radiology, Chinese People's Armed Police (PAP) Hospital of Beijing, Beijing, China.
  • Wang H; National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
  • Zhang X; Department of Radiology, Chinese People's Armed Police (PAP) Hospital of Beijing, Beijing, China.
  • Zhang X; Department of Radiology, Chinese People's Armed Police (PAP) Hospital of Beijing, Beijing, China.
  • He X; Department of Radiology, Chinese People's Armed Police (PAP) Hospital of Beijing, Beijing, China.
  • Zhang X; Department of Radiology, Chinese People's Armed Police (PAP) Hospital of Beijing, Beijing, China.
  • Qin B; Department of Oncology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
  • Li J; Department of Radiology, Characteristic Medical Center, Chinese People's Armed Police Force, Tianjin, China.
  • Zhang Z; Department of Radiology, Chinese People's Armed Police (PAP) Hospital of Beijing, Beijing, China.
  • Xue X; Department of Radiology, Chinese People's Armed Police (PAP) Hospital of Beijing, Beijing, China.
  • Wei Y; Department of Radiology, Chinese People's Armed Police (PAP) Hospital of Beijing, Beijing, China.
Front Immunol ; 13: 1064047, 2022.
Article em En | MEDLINE | ID: mdl-36605217

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Microambiente Tumoral / Imunoterapia Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Microambiente Tumoral / Imunoterapia Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China